These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 19187297)

  • 21. Antineutrophil cytoplasmic antibody-associated vasculitis with oculomotor nerve palsy.
    Seishima M; Mizutani Y; Shibuya Y; Arakawa C
    Clin Exp Dermatol; 2009 Mar; 34(2):171-3. PubMed ID: 19187297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Bronchiectasis worsening by p-ANCA (bactericidal/permeability-increasing protein) positive vasculitis. A case report and review of the literature].
    Benucci M; Nenci G; Taccetti G; Rosso A; Beltrame C; Cappelletti C; Manfredi M
    Ann Ital Med Int; 2005; 20(4):258-61. PubMed ID: 16610259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cutaneous vasculitis update: small vessel neutrophilic vasculitis syndromes.
    Carlson JA; Chen KR
    Am J Dermatopathol; 2006 Dec; 28(6):486-506. PubMed ID: 17122493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?
    Flossmann O; Jones RB; Jayne DR; Luqmani RA
    Ann Rheum Dis; 2006 Jul; 65(7):841-4. PubMed ID: 16769779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypotheses on the etiology of antineutrophil cytoplasmic autoantibody associated vasculitis: the cause is hidden, but the result is known.
    de Lind van Wijngaarden RA; van Rijn L; Hagen EC; Watts RA; Gregorini G; Tervaert JW; Mahr AD; Niles JL; de Heer E; Bruijn JA; Bajema IM
    Clin J Am Soc Nephrol; 2008 Jan; 3(1):237-52. PubMed ID: 18077783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rituximab in refractory antineutrophil cytoplasmic antibody-associated vasculitis: what is the current evidence?
    Wong CF
    Nephrol Dial Transplant; 2007 Jan; 22(1):32-6. PubMed ID: 17056639
    [No Abstract]   [Full Text] [Related]  

  • 27. New insight into the pathogenesis of vasculitis associated with antineutrophil cytoplasmic autoantibodies.
    Jennette JC; Falk RJ
    Curr Opin Rheumatol; 2008 Jan; 20(1):55-60. PubMed ID: 18281858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The continuing challenge of anti-neutrophil cytoplasm antibody-associated systemic vasculitis and glomerulonephritis.
    Pusey CD
    J Am Soc Nephrol; 2006 May; 17(5):1221-3. PubMed ID: 16624927
    [No Abstract]   [Full Text] [Related]  

  • 29. Remission in antineutrophil cytoplasmic antibody-associated systemic vasculitis.
    Mukhtyar C; Hellmich B; Jayne D; Flossmann O; Luqmani R
    Clin Exp Rheumatol; 2006; 24(6 Suppl 43):S-93-8. PubMed ID: 17083770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pathogenesis of antineutrophil-cytoplasmic antibody associated vasculitis].
    Yoshida M
    Arerugi; 2008 Jan; 57(1):32-6. PubMed ID: 18239443
    [No Abstract]   [Full Text] [Related]  

  • 31. ANCA-associated vasculitides: pathogenetic aspects and current evidence-based therapy.
    Holle JU; Gross WL
    J Autoimmun; 2009; 32(3-4):163-71. PubMed ID: 19345067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The diagnosis of vasculitis.
    Jayne D
    Best Pract Res Clin Rheumatol; 2009 Jun; 23(3):445-53. PubMed ID: 19508950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Models of antineutrophil cytoplasmic antigen-associated systemic vasculitis and their clinical relevance.
    Weening JJ; Heeringa P; Brouwer E; Tervaert JW; Kallenberg CG
    Adv Nephrol Necker Hosp; 1998; 28():63-81. PubMed ID: 9889986
    [No Abstract]   [Full Text] [Related]  

  • 34. Assessment of systemic vasculitis.
    Miller A; Basu N; Luqmani R
    Autoimmun Rev; 2008 Dec; 8(2):170-5. PubMed ID: 18672099
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antineutrophil cytoplasmic antibodies.
    Hoffman GS; Specks U
    Arthritis Rheum; 1998 Sep; 41(9):1521-37. PubMed ID: 9751084
    [No Abstract]   [Full Text] [Related]  

  • 36. Myeloperoxidase-antineutrophil cytoplasmic antibody seroconversion and fulminant vasculitis in Scl-70-positive scleroderma.
    Cheung G; Chew G; Wyndham R; Peters M; Riminton S
    Intern Med J; 2007 Mar; 37(3):205-7. PubMed ID: 17316347
    [No Abstract]   [Full Text] [Related]  

  • 37. The CARI guidelines. Induction and maintenance therapy in ANCA-associated systemic vasculitis.
    Menahem S; Hiremagalur B; Mudge D; Toussaint N; Walters G;
    Nephrology (Carlton); 2008 Jul; 13 Suppl 2():S24-36. PubMed ID: 18713121
    [No Abstract]   [Full Text] [Related]  

  • 38. Update on vasculitis.
    Khasnis A; Langford CA
    J Allergy Clin Immunol; 2009 Jun; 123(6):1226-36. PubMed ID: 19501230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oculomotor disorders.
    Rucker JC
    Semin Neurol; 2007 Jul; 27(3):244-56. PubMed ID: 17577866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Review article: Drug-induced anti-neutrophil cytoplasmic antibody-associated vasculitis.
    Gao Y; Zhao MH
    Nephrology (Carlton); 2009 Feb; 14(1):33-41. PubMed ID: 19335842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.